| Alpha Teknova is a producer of critical reagents for the research, discovery, development, and commercialization of therapies, vaccines, and molecular diagnostics. Co.'s product types are: pre-poured media plates for cell growth and cloning, liquid cell culture media and supplements for cellular expansion, and molecular biology reagents for sample manipulation, resuspension, and purification. Co.'s business lines are: Lab Essentials, which provides chemical formulations for use in biological research and drug discovery; and Clinical Solutions, which are custom products used in the production of protein therapies, gene therapies, messenger ribonucleic acid vaccines, and diagnostic kits. The TKNO average annual return since 2021 is shown above.
The Average Annual Return on the TKNO average annual return since 2021 page and across the coverage universe of our site,
is a measure of the annualized return over the past ten years (or specified start date) for a given investment
(up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement
period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window
to capture long-term trends.
Thus, researching Average Annual Returns is good practice for investors — whether TKNO average annual return since 2021 or other benchmarks/peers
— and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is
more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors
by performing the TKNO average annual return calculation with any dividends reinvested as applicable (on ex-dates).